46
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A population-based survey of Chronic REnal Disease In Turkey—the CREDIT study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background. Chronic kidney disease (CKD) is a growing health problem worldwide that leads to end-stage kidney failure and cardiovascular complications. We aimed to determine the prevalence of CKD in Turkey, and to evaluate relationships between CKD and cardiovascular risk factors in a population-based survey.

          Methods. Medical data were collected through home visits and interviews. Serum creatinine, blood glucose, total cholesterol, triglycerides, HDL, LDL and uric acid were determined from 12-h fasting blood samples, and spot urine tests were performed for subjects who gave consent to laboratory evaluation.

          Results. A total of 10 872 participants were included in the study. The final analysis was performed on 10 748 subjects (mean age 40.5 ± 16.3 years; 55.7% women) and excluded 124 pregnant women. A low glomerular filtration rate (GFR) (< 60 mL/min/1.73 m 2) was present in 5.2% of the subjects who were evaluated for GFR, while microalbuminuria and macroalbuminuria were observed in 10.2% and 2% of the subjects, respectively. The presence of CKD was assessed in subjects who gave consent for urinary albumin excretion measurement ( n  = 8765). The overall prevalence of CKD was 15.7%; it was higher in women than men (18.4% vs. 12.8%, P < 0.001) and increased with increasing age of the subjects. The prevalence of hypertension (32.7% in the general population), diabetes (12.7%), dyslipidaemia (76.3%), obesity (20.1%) and metabolic syndrome (31.3%) was significantly higher in subjects with CKD than subjects without CKD (P < 0.001 for all).

          Conclusions. The prevalence of CKD in Turkey is 15.7%. Cardiovascular risk factors were significantly more prevalent in CKD patients.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: not found
          • Article: not found

          Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.

            The aim of the European Action on Secondary and Primary Prevention by Intervention to Reduce Events III (EUROASPIRE III) survey was to determine whether the Joint European Societies' guidelines on cardiovascular prevention are being followed in everyday clinical practice and to describe the lifestyle, risk factor and therapeutic management in patients with coronary heart disease (CHD) in Europe. The EUROASPIRE III survey was carried out in 2006-2007 in 76 centres from selected geographical areas in 22 countries in Europe. Consecutive patients, with a clinical diagnosis of CHD, were identified retrospectively and then followed up, interviewed and examined at least 6 months after their coronary event. Thirteen thousand nine hundred and thirty-five medical records (27% women) were reviewed and 8966 patients were interviewed. At interview, 17% of patients smoked cigarettes, 35% were obese and 53% centrally obese, 56% had a blood pressure >or=140/90 mmHg (>or=130/80 in people with diabetes mellitus), 51% had a serum total cholesterol >or=4.5 mmol/l and 25% reported a history of diabetes of whom 10% had a fasting plasma glucose less than 6.1 mmol/l and 35% a glycated haemoglobin A1c less than 6.5%. The use of cardioprotective medication was: antiplatelets 91%; beta-blockers 80%; angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers 71%; calcium channel blockers 25% and statins 78%. The EUROASPIRE III survey shows that large proportions of coronary patients do not achieve the lifestyle, risk factor and therapeutic targets for cardiovascular disease prevention. Wide variations in risk factor prevalences and the use of cardioprotective drug therapies exist between countries. There is still considerable potential throughout Europe to raise standards of preventive care in order to reduce the risk of recurrent disease and death in patients with CHD.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement.

                Bookmark

                Author and article information

                Journal
                Nephrol Dial Transplant
                ndt
                ndt
                Nephrology Dialysis Transplantation
                Oxford University Press
                0931-0509
                1460-2385
                June 2011
                4 November 2010
                4 November 2010
                : 26
                : 6
                : 1862-1871
                Affiliations
                [1 ]Nephrology Division, Department of Medicine, simpleAkdeniz University Medical School , Antalya, Turkey
                [2 ]Nephrology Division, Department of Medicine, simpleErciyes University Medical Faculty , Kayseri, Turkey
                [3 ]Nephrology Division, Department of Medicine, simpleGazi University Medical Faculty , Ankara, Turkey
                [4 ]Nephrology Division, Department of Medicine, simpleAnkara University Medical Faculty , Ankara, Turkey
                [5 ]Nephrology Division, Department of Medicine, simpleHacettepe University Medical Faculty , Ankara, Turkey
                [6 ]Nephrology Division, Department of Medicine, simpleIstanbul University Cerrahpaşa Medical Faculty , Istanbul, Turkey
                [7 ]Nephrology Division, Department of Medicine, simpleIstanbul University Istanbul Medical Faculty , Istanbul, Turkey
                [8 ]Nephrology Division, Department of Medicine, simpleDicle University Medical Faculty , Diyarbakir, Turkey
                [9 ]Nephrology Division, Department of Medicine, simpleDokuz Eylül University Medical Faculty , Izmir, Turkey
                [10 ]Nephrology Division, Department of Medicine, simpleEge University Medical Faculty , Izmir, Turkey
                Author notes
                Correspondence and offprint requests to: Gültekin Süleymanlar; E-mail: gulteksu@ 123456superonline.com
                Article
                gfq656
                10.1093/ndt/gfq656
                3107767
                21051501
                61951f41-79a2-4097-984b-4d87d75edad6
                © The Author 2010. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 14 May 2010
                : 16 August 2010
                : 1 October 2010
                Categories
                Original Article

                Nephrology
                risk factors,epidemiology and outcomes,chronic kidney disease
                Nephrology
                risk factors, epidemiology and outcomes, chronic kidney disease

                Comments

                Comment on this article